Year’s Top 10 Lab Stories Contain Surprises & Twists

By Robert Michel | From the Volume XXX, Number 18 – December 26, 2023 Issue

CEO SUMMARY: With the SARS-CoV-2 pandemic now in the rearview mirror of the nation’s clinical labs and pathology groups, the important news stories of 2023 were mostly about developments where the consequences will influence laboratory operations in coming years. Artificial intelligence…

Read More

---

Three Labs Make Big Bets to Build Major New Facilities

By Joseph Burns | From the Volume XXVI No. 2 – February 4, 2019 Issue

EVEN AS SOME CLINICAL LABORATORY COMPANIES are closing or selling following the deep cuts in what Medicare pays for lab tests, three major lab organizations are building new, super-sized laboratory facilities. Those three companies are ARUP Laboratories, DaVita Labs…

Read More

---

Dartmouth-Hitchcock Builds Strong Lab Outreach Business

By Joseph Burns | From the Volume XXV No. 10 – July 9, 2018 Issue

CEO SUMMARY: As health networks and hospitals consider outsourcing their lab outreach programs, the lab team at Dartmouth-Hitchcock Medical Center (D-H) offers lessons about the value of retaining outreach. D-H is now in the eighth year of a sustained expansion of its laboratory outreach …

Read More

---

Theranos News Gets Worse for the Former Silicon Valley Hero

By R. Lewis Dark | From the Volume XXV No. 9 – June 18, 2018 Issue

CEO SUMMARY: In a tale of two fraudsters, the Department of Justice has filed a warning shot to all technology startups: Criminal indictments against Elizabeth Holmes and Ramesh “Sunny” Balwani could mean prison time and massive fines. In this latest Theranos news, The DOJ ci…

Read More

---

Holmes, Balwani Indicted by Department of Justice

By Joseph Burns | From the Volume XXV No. 9 – June 18, 2018 Issue

CEO SUMMARY: Federal criminal indictments were unsealed last Friday in San Francisco against Elizabeth Holmes and Ramesh “Sunny” Balwani for their actions as executives at Theranos, Inc., the once high-flying lab test company. Officials at the Department of Justice said the counts aga…

Read More

---

WSJ Reporter Tells All About Downfall of Troubled Theranos

By Joseph Burns | From the Volume XXV No. 8 – May 29, 2018 Issue

CEO SUMMARY: While Theranos was a darling of the business and national media, Wall Street Journal reporter John Carreyrou was hearing troubling reports about patients who got incongruent lab results that put them at risk for inappropriate medical…

Read More

---

How Many Patients Were Harmed at Theranos?

By Joseph Burns | From the Volume XXV No. 8 – May 29, 2018 Issue

CEO SUMMARY: Reporting in The Wall Street Journal shows that some physicians in Arizona were concerned about the harm from erroneous test results from Theranos Inc. But those physicians who expressed concern may have been only a small set of the …

Read More

---

SEC Charges Theranos with ‘Massive Fraud’

By Joseph Burns | From the Volume XXV No. 5 – March 26, 2018 Issue

CEO SUMMARY: In an action against Theranos and two of its executives, the SEC said in a federal court filing this month that the company, CEO Elizabeth Holmes, and former COO Ramesh “Sunny” Balwani deceived investors into believing that the company’s portable blood analyzer could co…

Read More

---

Newsmaker Interview: Healthcare’s Transformation Now Bringing Changes to Lab Industry

By Joseph Burns | From the Volume XXV No. 3 – February 12, 2018 Issue

“Today, patients want to get diagnosis and treatment faster with fewer visits to the doctor’s office. They want speedier and more comprehensive delivery of clinical services, be it laboratory tests, imaging, or other procedures.” …

Read More

---

Beckman Coulter Sues Quidel for Right to Sell BNP Assay

By Jon Stone | From the Volume XXV No. 1 – January 2, 2018 Issue

THERE IS AN INTERESTING COURT FIGHT UNFOLDING between Beckman Coulter Corporation and Quidel over the rights to sell a B-type natriuretic peptide (BNP) assay. The lawsuit is a consequence of Abbott Laboratories’ acquisition of Alere, Inc….

Read More

---